| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/02/2006 | DE102005026163A1 Gegen den Marburg I Polymorphismus der Faktor VII aktivierenden Protease (FSAP) gerichtete Antikörper, ihre Herstellung und Verwendung Against the Marburg I polymorphism of the factor VII-activating protease (FSAP) Antibodies, their production and use |
| 03/02/2006 | CA2829654A1 Small molecules that replace or agonize p53 function |
| 03/02/2006 | CA2810288A1 Apparatus for preparing multiple corn embryos suitable for tissue culture |
| 03/02/2006 | CA2578361A1 Binding member towards pneumolysin |
| 03/02/2006 | CA2578021A1 Modified human hepatitis c virus genomic rna that can be autonomously replicated |
| 03/02/2006 | CA2577201A1 A method of selecting a cardiomyocyte using intracellular mitochondria as an indicator |
| 03/02/2006 | CA2575863A1 Method and apparatus for substantially isolating plant tissues |
| 03/02/2006 | CA2572938A1 Genetically modified human natural killer cell lines |
| 03/02/2006 | CA2541827A1 Method for in situ repair of injured, damaged, diseased or aged articular cartilage using neo-cartilage constructs and a method for preparation thereof |
| 03/02/2006 | CA2510288A1 Bone regeneration |
| 03/01/2006 | EP1630231A2 Thermostable luciferases from photuris pennsylvanica and pyrophorus plagiophthalamus and methods of production |
| 03/01/2006 | EP1630229A2 Melanoma antigens |
| 03/01/2006 | EP1629106A2 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-beta-PROTEINS (TGF-betas) IN CELLS |
| 03/01/2006 | EP1629095A2 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
| 03/01/2006 | EP1629089A1 Selection and propagation of progenitor cells |
| 03/01/2006 | EP1628680A2 Hiv polynucleotides and polypeptides derived from botswana mj4 |
| 03/01/2006 | EP1628535A2 Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site |
| 03/01/2006 | EP1563084A4 Transgenic ungulates having reduced prion protein activity and uses thereof |
| 03/01/2006 | EP1417309A4 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof |
| 03/01/2006 | EP1389234B1 Cd8alpha + lymphoid dendritic cell differentiated from human hematopoietic stem cell and a method for differentiation |
| 03/01/2006 | EP1320583B1 Enhanced replication of hcv rna |
| 03/01/2006 | EP1305636B1 Screening method |
| 03/01/2006 | EP1297165B1 Promoters for gene expression in caryopses of plants |
| 03/01/2006 | EP1290205B1 Duplexed parvovirus vectors |
| 03/01/2006 | EP1290139B1 METHODS FOR ASSAYING GENE IMPRINTING AND METHYLATED CpG ISLANDS |
| 03/01/2006 | EP1143983B1 Spray delivery of cells |
| 03/01/2006 | EP1141252B1 Human delta 5-desaturase gene and uses thereof |
| 03/01/2006 | EP1141250B1 Intein-mediated cyclization of peptides |
| 03/01/2006 | EP1092035B1 Targeted integration into chromosomes using retroviral vectors |
| 03/01/2006 | EP0998569B1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
| 03/01/2006 | EP0932678B1 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 03/01/2006 | EP0931148B1 Fibroblast growth factor homologs |
| 03/01/2006 | EP0920498B1 Hamster ef-1alpha transcriptional regulatory dna |
| 03/01/2006 | EP0907735B1 Modulators of tissue regeneration |
| 03/01/2006 | EP0859833B1 Recombinant hepatitis c virus rna replicase |
| 03/01/2006 | EP0840750B1 Ha-2 antigenic peptide |
| 03/01/2006 | EP0783526B1 Growth blocking agents to the vitamin b12 binding sites on transcobalamin ii |
| 03/01/2006 | EP0711351B1 Wax esters in transformed plants |
| 03/01/2006 | CN1742088A Transgenic ungulates having reduced prion protein activity and uses thereof |
| 03/01/2006 | CN1742085A Gene for increasing crop yield and use thereof |
| 03/01/2006 | CN1742082A Primitive and proximal hepatic stem cells |
| 03/01/2006 | CN1742081A Anterior ocular-associated cell sheet three-dimensional construct and process for producing the same |
| 03/01/2006 | CN1742080A Magnetic cell and method of using the same |
| 03/01/2006 | CN1742079A Biodegradable dual porous scaffold wrapped with semi-permeable membrane and tissue cell culture using thereof |
| 03/01/2006 | CN1741817A A hepatitis c virus codon optimized non-structural NS3/4A fusion gene |
| 03/01/2006 | CN1741816A Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom |
| 03/01/2006 | CN1741777A Methods and devices for selective disruption of fatty tissue by controlled cooling |
| 03/01/2006 | CN1740316A Anti-swine infectious enterogastritis recombinant N protein hybridoma cell strain |
| 03/01/2006 | CN1740315A A transgenic mouse liver disease animal model producing process and application thereof |
| 03/01/2006 | CN1739809A Titanium net with fimbrin and its prepn and application |
| 03/01/2006 | CN1243830C Novel mouse CXC chemotactic receptor |
| 03/01/2006 | CN1243771C Novel alginate monoclonal antibody and its preparation method and use |
| 03/01/2006 | CN1243770C Neurotrophic growth factor |
| 02/28/2006 | US7005567 Rice hybrid RH102 |
| 02/28/2006 | US7005566 Hybrid maize plant and seed 33M54 |
| 02/28/2006 | US7005565 Soybean variety XB40E05 |
| 02/28/2006 | US7005563 Genetically engineered seeds for generating and propagating disease, insects, drought and heat resistant plants; tissue engineering; improving agronomic, stem and root quality |
| 02/28/2006 | US7005511 Fluorescent protein variants and methods for making same |
| 02/28/2006 | US7005509 Pancreatic expressed chemokines, (PANEC-1); expression vectors, host cells, and diagnostic tests using probes for physiologic or pathologic compromise of the pancreas |
| 02/28/2006 | US7005503 High throughput screening of antibody libraries against membrane proteins; chemokines; infection inhibition |
| 02/28/2006 | US7005424 Admininstering mixtures of anticarcinogenic agents and early genes for prophylaxis of cancer, tumors or metastasis; gene expression inhibitors |
| 02/28/2006 | US7005423 identifying DNA responsible for conferring a phenotype of a Caenorhabditis elegans (C. elegans) cell or organism |
| 02/28/2006 | US7005415 Wherein the DNA synthesis promoting activity of the heparin-binding protein is increased by the covalently bonded sugar chain which can be heparan sulfate; improved in vivo stabilities such as acid resistance and alkali resistance |
| 02/28/2006 | US7005411 Method for modulating nerve cell function |
| 02/28/2006 | US7005299 gene trap vector containing expression unit of internal ribosome binding site coupled to heterologous gene sequence (antibiotic resistance), for insertion/transformation within mouse embryonic stem cell; homologous recombination |
| 02/28/2006 | US7005298 Micropropagation and production of phytopharmaceutical plants |
| 02/28/2006 | US7005297 Use of neuroactive compounds |
| 02/28/2006 | US7005295 β-amyloid peptide-binding proteins and polynucleotides encoding the same |
| 02/28/2006 | US7005289 Polynucleotide derived from fungal source which comprises a nucleotide sequence encoding an enzyme having beta-glucosidase activity |
| 02/28/2006 | US7005285 Human p21-activated kinase 5 polypeptide |
| 02/28/2006 | US7005277 Defective adenoviruses and corresponding complementation lines |
| 02/28/2006 | US7005276 missense mutagenesis; blood testing; host cells; kits |
| 02/28/2006 | US7005275 Inducible alphaviral gene expression system |
| 02/28/2006 | US7005252 Serum free cultivation of primate embryonic stem cells |
| 02/28/2006 | US7005131 Protective antigen of Epstein Barr Virus |
| 02/28/2006 | US7005127 Mixed-cell gene therapy |
| 02/28/2006 | US7005126 Administering near the tumor xenogeneic retroviral vector producer cells having alpha (1,3)galactosyl epitopes to activate a hyperacute rejection response; treatment is not followed with ganciclovir; ovarian tumors for example |
| 02/24/2006 | CA2516876A1 Antibodies which are directed against the marburg i polymorphism of factor vii-activating protease (fsap), and their preparation and use |
| 02/23/2006 | WO2006020958A2 Organogenesis from dissociated cells |
| 02/23/2006 | WO2006020954A1 Isolation of endothelial progenitor cell subsets and methods for their use |
| 02/23/2006 | WO2006020919A2 Compositions and methods for self-renewal and differentiation in human embryonic stem cells |
| 02/23/2006 | WO2006020889A2 Dendritic cell vaccines for treating cancer made from embryonic stem cells |
| 02/23/2006 | WO2006020684A2 Methods of regulating differentiation and treating of multiple myeloma |
| 02/23/2006 | WO2006020594A2 Cloning and expression of recombinant adhesive protein mefp-1 of the blue mussel, mytilus edulis |
| 02/23/2006 | WO2006020319A2 Methods and compositions for producing target cell reactive lymphocytes in a subject |
| 02/23/2006 | WO2006020240A2 Methods and compositions for bioengineering a tooth |
| 02/23/2006 | WO2006019366A1 Physiochemical culture conditions for embryonic stem cells |
| 02/23/2006 | WO2006019357A1 Isolation of stem/progenitor cells from amniotic membrane of umbilical cord. |
| 02/23/2006 | WO2006019194A1 Cap-independent rna translation efficiency controller and utilization of the same |
| 02/23/2006 | WO2006019192A1 POLYPEPTIDE HAVING ACTIVITY OF UNSATURATING ω3-FATTY ACID, POLYNUCLEOTIDE CODING FOR THE POLYPEPTIDE AND USE THEREOF |
| 02/23/2006 | WO2006019153A1 NONHUMAN ANIMAL WITH INHIBITED GdsmA GENE FUNCTION AND PROMOTED OR INHIBITIED CANCERATION-ASSOCIATED GENE FUNCTION |
| 02/23/2006 | WO2006019095A1 Novel urethanase gene |
| 02/23/2006 | WO2006018998A1 Method of constructing clone mammal |
| 02/23/2006 | WO2006018849A2 Non-invasive prenatal genetic diagnosis using transcervical cells |
| 02/23/2006 | WO2006018836A2 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 02/23/2006 | WO2006018676A1 Aquaculture and/or mariculture method stimulation water system with feeding/precursor |
| 02/23/2006 | WO2006018674A1 Tr1 cells for use in atherosclerosis |
| 02/23/2006 | WO2006018298A1 Substrate, method for the production thereof and use thereof in order to form cultures of organic cells |
| 02/23/2006 | WO2006017961A1 Monoclonal antibody(ad5-10) against tumor necrosis factor-related apoptosis-inducing ligand receptor dr5, the producing method and uses thereof |
| 02/23/2006 | WO2006017954A1 PREPARATION OF ANTIGEN-PRESENTING HUMAN Ϝδ T CELLS AND USE IN IMMUNOTHERAPY |